[Noonan syndrome].
Ogata
Tsutomu
T
Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development.
D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000502:physiology; D009154:Mutation; D009634:Noonan Syndrome / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11; D017027:Protein Tyrosine Phosphatases / Q000235:genetics / Q000502:physiology
D047908:Intracellular Signaling Peptides and Proteins; D019382:Human Growth Hormone; C516724:PTPN11 protein, human; D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11; D017027:Protein Tyrosine Phosphatases